SCHEMBL4063929

SCHEMBL4063929

CCCC(O)CNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL964941 0.84
SCHEMBL12807536 0.82 GPR84 (0.47)
SCHEMBL11078546 0.82 GPR84 (0.47)
SCHEMBL10613218 0.81
SCHEMBL965751 0.80 GPR84 (0.50)
SCHEMBL6554143 0.80 GPR84 (0.50)
SCHEMBL964723 0.80 GPR84 (0.50)
SCHEMBL965155 0.80 GPR84 (0.50)
SCHEMBL19711749 0.80 GPR84 (0.50)
SCHEMBL963283 0.80 GPR84 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922564-B Trimerization catalysts from sterically hindered salts and tertiary amines having isocyanate-reactive groups 赢创运营有限公司 2021-10-19 CN claimed
EP-2061776-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE Wyeth a Corporation of the State of Delaware (US) 2009-05-27 EP claimed
WO-2008073459-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO claimed
US-11639347-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-05-02 US disclosed
EP-2536716-B1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-05-21 EP disclosed
EP-2061776-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE Wyeth a Corporation of the State of Delaware (US) 2009-05-27 EP disclosed
WO-2008073459-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO disclosed
US-20070142413-A1 Pyrazole derivatives as inhibitors of receptor tyrosone kinases ASTRAZENECA AB (SE) 2007-06-21 US disclosed
CN-1210264-C 1,3-dialkyl-2-imidazolinones and its prepn. MITSUI CHEMICALS INC (JP) 2005-07-13 CN disclosed
EP-0992497-B1 Manufactoring process for 1,3-Dialkyl-2-imidazolinones MITSUI CHEMICALS INC (JP) 2003-12-17 EP disclosed
US-6492528-B1 1,3-DIALKYL-2-IMIDAZOLIDINONES IN A DIRECT ONE-STEP REACTION FROM INDUSTRIALLY AVAILABLE ALKYLENE CARBONATE, N-ALKYLETHANOLAMINE OR 1,2-DIOL, WHICH CAN MINIMIZE FORMING SOLID MATERIALS AND BE READILY CONDUCTED IN AN INDUSTRIAL MITSUI CHEMICALS, INC. (JP) 2002-12-10 US disclosed
EP-1148052-A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
EP-1148051-A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
CN-1256268-A 1,3-dialkyl-2-imidazolinones and its prepn. MITSUI CHEMICALS INC (JP) 2000-06-14 CN disclosed
EP-0992497-A1 1,3-Dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2000-04-12 EP disclosed
EP-0912693-A2 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1999-05-06 EP disclosed
WO-1997043391-A2 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-11-20 WO disclosed